Search Ontology:
ChEBI

azilsartan medoxomil

Term ID
CHEBI:68845
Synonyms
  • (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1-benzimidazole-7-carboxylate
  • azilsartan medoxomil
  • azilsartan medoxomilo
  • azilsartanum medoxomilum
  • Edarbi
Definition
A carboxylic ester obtained by formal condensation of the carboxy group of azilsartan with the hydroxy group of 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one. A prodrug for azilsartan, it is used for treatment of hypertension.
References
  • cas:863031-21-4
  • drugcentral:4322
  • kegg.drug:D08067
  • patent:US2005187269
  • pubmed:21069103
  • pubmed:21272195
  • pubmed:21282560
  • pubmed:21555300
  • pubmed:21558880
  • pubmed:21566544
  • pubmed:21762358
  • pubmed:21816148
  • pubmed:21971539
  • pubmed:21986624
  • pubmed:22071238
  • pubmed:22116996
  • pubmed:22346296
  • pubmed:22365278
  • pubmed:22457601
  • pubmed:22533654
  • pubmed:22661897
  • pubmed:22710649
  • pubmed:22877322
  • pubmed:22939358
  • reaxys:12326818
  • wikipedia.en:Azilsartan
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from azilsartan medoxomil
Phenotype where environments contain azilsartan medoxomil
Phenotype modified by environments containing azilsartan medoxomil
Phenotype affecting azilsartan medoxomil
Human Disease Model